Business Description
CytoDyn Inc. is a Washington-based medical research company focused on developing a drug called leronlimab, which works by blocking a specific protein receptor in the body. The company is currently running clinical trials to explore how this drug might help patients with certain cancers, including colorectal cancer and triple-negative breast cancer. Founded in 2002, CytoDyn works alongside partner organization Creatv Bio to advance its research goals.
